Pharmacy Focus: Oncology Edition

In the first episode of Pharmacy Focus: Oncology Edition, we spoke with Ron Lanton, JD, principal at Lanton Law.

Kirollos Hanna, PharmD, BCPS, BCOP, discussed how PARP inhibitors have changed the treatment landscape of ovarian cancer.

This month, we reviewed key topics and interviews from the American Society of Clinical Oncology 2022 Annual Meeting.

This month, we spoke with Bob Luschen, PharmD, clinical coordinator for the pharmacy department at cancer Treatment Centers of America, Atlanta.

As treatments improve and prostate cancer potentially becomes more of a chronic illness, pharmacists have a chance to shine.

CAR T therapies are potentially revolutionizing the treatment of acute lymphoblastic leukemia (ALL).

Pharmacists can be involved in all aspects of care, from deciding treatment plans to educating patients, and in the growing role of oral treatments.

This month, we spoke with Danielle Roman, PharmD, an oncology clinical pharmacy specialist with Allegheny Health Network.

This month, we have a special crossover episode between Pharmacy Focus: Oncology Edition and the Psychedelic Pharmacy podcast.

This month, we spoke with Cassia Griswold, PharmD, a clinical oncology pharmacist at Mayo Clinic Arizona.

The updated version of the Oncology Care Model (OCM) incentivizes value-based care over volume, but some wonder if it is enough.

A brief overview of 4 recent developments in the treatment of non-small cell lung cancer.

The podcast discusses how City of Hope Chicago fully integrates oncology pharmacists into care teams by positioning them in clinics, improving communication and collaboration to minimize delays for patients and enhance care delivery.

Pharmacists from Mayo Clinic recap some of the latest treatment opportunities to advance patient care in the oncology space.

The PALOMA-3 trial showed subcutaneous amivantamab was better than IV among lung cancer patients.

Jennifer Dunphy, DrPH, MBA, MPH and Nelly Awkar-Lazo, MD, discuss the rise in young-onset cancer, the gut-colon cancer link, and the importance of healthy lifestyle choices for cancer prevention.

Expert shares reasons why many women are behind on their annual breast cancer screenings, along with the latest cutting edge treatments in the breast cancer space.

Thomas Chen, MD, PhD discussed his innovative approach to brain cancer treatment through NeOnc, Inc.

Expert discussed the potential of pelareorep, a novel immunotherapeutic agent, in treating advanced or metastatic breast cancer.

Expert discussed benefits of precision oncology treatments that utilize thousands of biomarkers to design personalized treatment plans.

Pharmacy Times attended the 2024 San Antonio Breast Cancer Symposium from December 10 to December 13.

Expert weighs in on data from the AQUILA trial and Johnson & Johnson's approval request for daratumumab for smoldering multiple myeloma.

Colorectal cancer cases are on the rise—here is everything you need to know as an oncology pharmacist.

Pharmacists share key insights about the use of ADCs for treatment of breast cancer.

Explore the impact of the Inflation Reduction Act on community oncology practices and discover how new legislation aims to protect patient access to care.

Experts discuss radon—the second leading cause of lung cancer.